Date of Report (Date of earliest event reported):
|
July 26, 2012
|
MERIDIAN BIOSCIENCE, INC.
|
(Exact name of registrant as specified in its charter)
|
Ohio
|
0-14902
|
31-0888197
|
||
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No. )
|
3471 River Hills Drive, Cincinnati, Ohio
|
45244
|
|
(Address of principal executive offices)
|
(Zip Code)
|
Registrant’s telephone number, including area code
|
(513) 271-3700
|
(Former name or former address, if changed since last report.)
|
o
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
o
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
o
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
o
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
99.1
|
Press Release dated July 26, 2012.
|
MERIDIAN BIOSCIENCE, INC.
|
|||
Date: July 26, 2012
|
By:
|
/s/ Melissa A. Lueke | |
Melissa A. Lueke | |||
Executive Vice President and
Chief Financial Officer
|
|||
(Principal Accounting Officer) |